Tiago Fauth

Stock Analyst at Wells Fargo

(0)
# 4651
Out of 5,370 analysts
171
Total ratings
36.89%
Success rate
-14.38%
Average return
45 Stocks
Name Action PT Current % Upside Ratings Updated
LQDA Liquidia
Maintains: Overweight
23 25
14.13 76.93% 2 Jun 12, 2025
INSM Insmed
Maintains: Overweight
107 119
101.26 17.52% 4 Jun 11, 2025
SVRA Savara
Maintains: Overweight
8 7
2.19 219.63% 2 May 28, 2025
PTCT PTC Therapeutics
Maintains: Overweight
68 74
51.79 42.88% 2 May 27, 2025
INZY Inozyme Pharma
Downgrades: Equal-Weight
4
3.98 0.5% 3 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
93 107
92.58 15.58% 5 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
395 314
288.31 8.91% 5 Apr 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
112 101
21.35 373.07% 4 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
275 287
308.78 -7.05% 5 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
4 3
1.34 123.88% 2 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
28 26
13.63 90.76% 6 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
18 17
6.05 180.99% 1 Feb 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
75 88
37.03 137.65% 7 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
9
3.81 136.22% 1 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
11 22
6.84 221.64% 2 Oct 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
75
51.94 44.4% 1 Aug 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
1225 70
n/a n/a 2 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
63 62
2.54 2340.94% 5 Aug 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
89
177.69 -49.91% 16 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
51
15.93 220.15% 3 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Outperform
120
56.19 113.56% 7 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
120
n/a n/a 6 May 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Underperform
4
15.48 -74.16% 4 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
22 17
n/a n/a 2 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
14
2.81 398.22% 4 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
4
n/a n/a 5 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
26
6.48 301.23% 5 May 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 28
3.16 786.08% 7 May 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
70 81
18.32 342.14% 11 May 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
139 200
n/a n/a 5 Apr 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Underperform
1
n/a n/a 3 Apr 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
8
n/a n/a 5 Mar 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
14
1.21 1057.02% 2 Mar 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
38 34
0.53 6315.09% 2 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
150
3.17 4631.86% 2 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
29
41.74 -30.52% 1 Jan 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
13
1.75 642.86% 1 Dec 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 13
2.15 504.65% 2 Nov 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20
n/a n/a 3 Sep 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
3 2
0.78 156.41% 4 May 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
297 340
551.73 -38.38% 3 Dec 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 18
n/a n/a 2 Sep 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
102 98
n/a n/a 1 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
265 259
295.12 -12.24% 1 Apr 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
60 42
n/a n/a 5 Nov 10, 2020